Jen Nwankwo, 1910 Genetics CEO
March 23, 2021 10:01 AM EDTUpdated 04:22 PM
Startups
AI

Ex­clu­sive: Mi­crosoft, Sam Alt­man back a new AI biotech up­start

Jason Mast

Editor

Most ar­ti­fi­cial in­tel­li­gence biotechs start with a com­put­er sci­en­tist or two and an al­go­rithm. Jen Nwankwo start­ed from the oth­er side of the spec­trum. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump says he'll sign or­der on 'most fa­vored na­tion' drug price plans Mon­day

Lil­ly says fur­ther head-to-head tri­al da­ta back Zep­bound over No­vo’s We­govy

Lil­ly shuf­fles key ex­ec­u­tive po­si­tions; Mikael Dol­sten takes an­oth­er post-Pfiz­er as­sign­ment

From deal to dis­as­ter: Drug­mak­ers face a changed Wash­ing­ton as Trump em­braces ‘most fa­vored na­tion’ prices

Rev­o­lu­tion’s KRAS drugs ap­pear com­pet­i­tive in sev­er­al lung can­cer set­tings

Io­vance stock plum­mets af­ter low­ered full-year guid­ance, missed an­a­lyst ex­pec­ta­tions for Am­tagvi

A service from the Financial Times